HIV-AIDS Cure News 2017: Dr. Ezeibe's HIV-AIDS Medicine Claims Met With Mixed Reactions
Modern medicine's fight against Human Immuno-deficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) has been a myriad of unverified claims of possible cures. There are controversial breakthroughs of many scientists all over the world, the most recent one originating from Prof. Maduike Ezeibe of Maichael Okpara University of Agriculture Umudike (MOUAU), Abia State in Nigeria.
Dr. Ezeibe, who is also the head of the university's Department of Veterinary Medicine, recently revealed to the media that he has invented medicine called Medicinal synthetic Aluminum-magnensium silicate (MSAMS), which he claims to have the capacity to cure HIV-AIDS.
According to Dr. Ezeibe, the small size of the molecules of the medicine's components allows the medication to reach HIV anywhere in the body, and the electrostatic attraction between the negative charges on the surfaces of the medicine's components and the positive charges on HIV mops out the virus.
Get Our Latest News for FREE
In addition, MSAMS is a silicate, causing the proliferation of lymphocytes. Hence, the synergy between the antiviral effects of the medicine as well as the increased population of the body's lymphocytes is what cures HIV-AIDS.
"With this invention, we have succeeded and also defended it," Dr. Ezeibe said, according to The Guardian. "The invention was taken to scientific journals for peer review because you do not announce inventions over the media. You do so through the journals for scientists to do a review of it. The publications we made were reviewed and accepted worldwide," he added.
"Through our laboratory tests, we found out that the medicine, Medicinal Synthetic Aluminum-Magnesium Silicate (MSAMS), was able to inhibit the virus," he added. "We then sent it to British Journal of Medicine and Medical Research (BJMMR). After its success and confirmation, they published it," he continued.
Since Dr. Ezeibe's proclamation that he has found a cure for HIV/AIDS, the validity of his findings has been put into question.
In fact, Nigeria's National Agency for the Control of AIDS (NACA) and Nigeria Centres for Disease Control and Prevention (NCDC) has criticized Dr. Ezeibe for allegedly not following established procedures before publicizing his findings.
According to Dr. Sani Aliyu, the director general of NACA, Dr. Ezeibe did not show sufficient evidence that he obtained ethical clearance from an appropriate governing body in Nigeria to conduct the study.
"We are concerned that the publicity given to these claims will stop patients from taking life-saving antiretrovirals and give them false hope of a cure. It will be a great disservice to this vulnerable group of patients for the media to disseminate these claims in absence of sound scientific evidence," Aliyu said.
As Dr. Ezeibe's claims of inventing a cure for HIV-AIDS are met with mixed reactions, the professor of MOUAU's Department of Veterinary Medicine has been invited to present his paper - "Responses of patients at different stages of HIV-infection, to treatment with Medicinal synthetic Aluminum-magnesium silicate's {Al4 (SiO4) 3 + 3Mg2SiO4 → 2Al2Mg3(SiO4) 3}" – at the 2017 and 3rd International Conference On "Retroviruses and Novel Drugs.
The conference is scheduled to take place on July 27–28 in Vancouver, Canada.
